Clinical Trials Browser

NETWORK × Temozolomide × Gastrointestinal × Clear all

NCT04796454 2022-06-01

PAMICC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT00005597 2013-01-03

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors